These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12676958)

  • 1. Leads for development of new naphthalenesulfonate derivatives with enhanced antiangiogenic activity: crystal structure of acidic fibroblast growth factor in complex with 5-amino-2-naphthalene sulfonate.
    Fernández-Tornero C; Lozano RM; Redondo-Horcajo M; Gómez AM; López JC; Quesada E; Uriel C; Valverde S; Cuevas P; Romero A; Giménez-Gallego G
    J Biol Chem; 2003 Jun; 278(24):21774-81. PubMed ID: 12676958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution structure of acidic fibroblast growth factor bound to 1,3, 6-naphthalenetrisulfonate: a minimal model for the anti-tumoral action of suramins and suradistas.
    Lozano RM; Jiménez M; Santoro J; Rico M; Giménez-Gallego G
    J Mol Biol; 1998 Sep; 281(5):899-915. PubMed ID: 9719643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution structure and interaction with basic and acidic fibroblast growth factor of a 3-kDa human platelet factor-4 fragment with antiangiogenic activity.
    Lozano RM; Redondo-Horcajo M; Jimenez MA; Zilberberg L; Cuevas P; Bikfalvi A; Rico M; Giménez-Gallego G
    J Biol Chem; 2001 Sep; 276(38):35723-34. PubMed ID: 11423536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naphthalene-sulfonate inhibitors of human norovirus RNA-dependent RNA-polymerase.
    Tarantino D; Pezzullo M; Mastrangelo E; Croci R; Rohayem J; Robel I; Bolognesi M; Milani M
    Antiviral Res; 2014 Feb; 102():23-8. PubMed ID: 24316032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular level interaction of the human acidic fibroblast growth factor with the antiangiogenic agent, inositol hexaphosphate .
    Kumar SM; Wang HM; Mohan SK; Chou RH; Yu C
    Biochemistry; 2010 Dec; 49(50):10756-64. PubMed ID: 21077672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Destabilization, oligomerization and inhibition of the mitogenic activity of acidic fibroblast-growth factor by aurintricarboxylic acid.
    Lozano RM; Rivas G; Giménez-Gallego G
    Eur J Biochem; 1997 Aug; 248(1):30-6. PubMed ID: 9310356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel ligand binding motif in the transthyretin channel.
    Lima LM; Silva Vde A; Palmieri Lde C; Oliveira MC; Foguel D; Polikarpov I
    Bioorg Med Chem; 2010 Jan; 18(1):100-10. PubMed ID: 19954984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional structure of acidic fibroblast growth factor in solution: effects of binding to a heparin functional analog.
    Pineda-Lucena A; Jiménez MA; Lozano RM; Nieto JL; Santoro J; Rico M; Giménez-Gallego G
    J Mol Biol; 1996 Nov; 264(1):162-78. PubMed ID: 8950275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors.
    Laird AD; Vajkoczy P; Shawver LK; Thurnher A; Liang C; Mohammadi M; Schlessinger J; Ullrich A; Hubbard SR; Blake RA; Fong TA; Strawn LM; Sun L; Tang C; Hawtin R; Tang F; Shenoy N; Hirth KP; McMahon G; Cherrington
    Cancer Res; 2000 Aug; 60(15):4152-60. PubMed ID: 10945623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct and allosteric inhibition of the FGF2/HSPGs/FGFR1 ternary complex formation by an antiangiogenic, thrombospondin-1-mimic small molecule.
    Pagano K; Torella R; Foglieni C; Bugatti A; Tomaselli S; Zetta L; Presta M; Rusnati M; Taraboletti G; Colombo G; Ragona L
    PLoS One; 2012; 7(5):e36990. PubMed ID: 22606323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Undersulfated and glycol-split heparins endowed with antiangiogenic activity.
    Casu B; Guerrini M; Guglieri S; Naggi A; Perez M; Torri G; Cassinelli G; Ribatti D; Carminati P; Giannini G; Penco S; Pisano C; Belleri M; Rusnati M; Presta M
    J Med Chem; 2004 Feb; 47(4):838-48. PubMed ID: 14761186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution structure of human acidic fibroblast growth factor and interaction with heparin-derived hexasaccharide.
    Ogura K; Nagata K; Hatanaka H; Habuchi H; Kimata K; Tate S; Ravera MW; Jaye M; Schlessinger J; Inagaki F
    J Biomol NMR; 1999 Jan; 13(1):11-24. PubMed ID: 10070748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural studies of the binding of the anti-ulcer drug sucrose octasulfate to acidic fibroblast growth factor.
    Zhu X; Hsu BT; Rees DC
    Structure; 1993 Sep; 1(1):27-34. PubMed ID: 7520817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex.
    Venkataraman G; Raman R; Sasisekharan V; Sasisekharan R
    Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3658-63. PubMed ID: 10097093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinazoline-based multi-tyrosine kinase inhibitors: synthesis, modeling, antitumor and antiangiogenic properties.
    Conconi MT; Marzaro G; Urbani L; Zanusso I; Di Liddo R; Castagliuolo I; Brun P; Tonus F; Ferrarese A; Guiotto A; Chilin A
    Eur J Med Chem; 2013 Sep; 67():373-83. PubMed ID: 23900004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An S116R Phosphorylation Site Mutation in Human Fibroblast Growth Factor-1 Differentially Affects Mitogenic and Glucose-Lowering Activities.
    Xia X; Kumru OS; Blaber SI; Middaugh CR; Li L; Ornitz DM; Suh JM; Atkins AR; Downes M; Evans RM; Tenorio CA; Bienkiewicz E; Blaber M
    J Pharm Sci; 2016 Dec; 105(12):3507-3519. PubMed ID: 27773526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of rat acidic fibroblast growth factor at 1.4 A resolution.
    Kulahin N; Kiselyov V; Kochoyan A; Kristensen O; Kastrup JS; Berezin V; Bock E; Gajhede M
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Feb; 63(Pt 2):65-8. PubMed ID: 17277441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion of type I 4:6 to 3:5 beta-turn types in human acidic fibroblast growth factor: effects upon structure, stability, folding, and mitogenic function.
    Lee J; Dubey VK; Somasundaram T; Blaber M
    Proteins; 2006 Mar; 62(3):686-97. PubMed ID: 16355415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of nucleotides with acidic fibroblast growth factor (FGF-1).
    Chavan AJ; Haley BE; Volkin DB; Marfia KE; Verticelli AM; Bruner MW; Draper JP; Burke CJ; Middaugh CR
    Biochemistry; 1994 Jun; 33(23):7193-202. PubMed ID: 7516183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes.
    Ostrovsky O; Berman B; Gallagher J; Mulloy B; Fernig DG; Delehedde M; Ron D
    J Biol Chem; 2002 Jan; 277(4):2444-53. PubMed ID: 11714710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.